LobbyingPharma & Biopharma Outsourcing Association lobbying by quarter
Pharma & Biopharma Outsourcing Association's latest lobbying report covers Q2 2026, at $100K. The four quarters Q3 2025–Q2 2026 total $400K. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Health Issues.
Pharma & Biopharma Outsourcing Association
- Latest quarter
- $100K
- Q2 2026 · 2 reports
- Last 12 months
- $400K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 2 |
| Q1 2023 | $100K | 2 |
| Q2 2023 | $100K | 2 |
| Q3 2023 | $100K | 2 |
| Q4 2023 | $100K | 2 |
| Q1 2024 | $100K | 2 |
| Q2 2024 | $100K | 2 |
| Q3 2024 | $100K | 2 |
| Q4 2024 | $100K | 2 |
| Q1 2025 | $100K | 2 |
| Q2 2025 | $100K | 2 |
| Q3 2025 | $100K | 2 |
| Q4 2025 | $100K | 2 |
| Q1 2026 | $100K | 2 |
| Q2 2026 | $100K | 2 |
Policy issues the reports name
- Pharmacy30 reports
- Health issues15 reports
- Manufacturing15 reports
- Tariffs5 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES29 reports
- SENATE27 reports
- White House Office6 reports
- Bureau of Industry and Security (BIS)3 reports
- Commerce, Dept of (DOC)2 reports
- State, Dept of (DOS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| BGR Government Affairs | $750K | 15 quarters |
| In-housePharma & Biopharma Outsourcing Association | $750K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRENT ALAN DEL MONTE | Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee | Q2 2026 |
| GIL ROTH | not applicable | Q2 2026 |
| JOHN STONE | Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C | Q2 2026 |
| REMY LEIGH BRIM MASON | Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz | Q2 2026 |
| DANIEL FARMER | St. Asst Rep. Debbie Wasserman Schultz; Leg. Corr. Rep. Debbie Wasserman Schultz; Leg. Corr./Leg. Asst. Rep. Debbie Wasserman Schultz; Leg. Asst. Rep. Zack Space; Sr. Leg. Asst. Rep. Zack Space; Leg. Dir. Zack Space | Q2 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | BGR Government Affairs | $50K |
| 07/14for Q2 | In-house | $50K |
| 04/22for Q1 | In-house | $50K |
| 04/20for Q1 | BGR Government Affairs | $50K |
| 01/20for Q4 2025 | BGR Government Affairs | $50K |
| 01/16for Q4 2025 | In-house | $50K |
| 25/10/20for Q3 2025 | BGR Government Affairs | $50K |
| 25/10/01for Q3 2025 | In-house | $50K |
| 25/10/01for Q3 2025 | In-house | $50K |
| 25/07/21for Q2 2025 | BGR Government Affairs | $50K |
| 25/07/08for Q2 2025 | In-house | $50K |
| 25/04/21for Q1 2025 | BGR Government Affairs | $50K |
| 25/04/18for Q1 2025 | In-house | $50K |
| 25/01/20for Q4 2024 | BGR Government Affairs | $50K |
| 25/01/02for Q4 2024 | In-house | $50K |
| 24/10/21for Q3 2024 | BGR Government Affairs | $50K |
| 24/10/04for Q3 2024 | In-house | $50K |
| 24/07/22for Q2 2024 | BGR Government Affairs | $50K |
| 24/07/10for Q2 2024 | In-house | $50K |
| 24/05/02for Q1 2024 | In-house | $50K |